首页 › 基金 › Avalon Trust Co › PPH
Avalon Trust Co 对 PPH 的持仓历史
VANECK PHARMACEUTICAL ETF
Avalon Trust Co 在 Q3 2026 的 13F 申报中披露持有 PPH(VANECK PHARMACEUTICAL ETF)254,155 股,市值约 US$27.8M,约占其申报组合的 1.74%,在其申报持仓中市值排名第 13 位。 Avalon Trust Co 最近 13 个申报季度中有 13 个季度披露了 PPH 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Avalon Trust Co 对 PPH 的持仓演变
Avalon Trust Co 于 Q3 2023 首次披露 PPH 持仓:287,575 股(约 US$23.0M)。 该持仓在 Q2 2026 达到峰值 263,830 股,市值约 US$28.8M。 在 13 次申报中,Avalon Trust Co 0 次增持、7 次减持、5 次保持不变。 最近一期申报(Q3 2026)显示持股 254,155 股、市值约 US$27.8M,环比减持 -9,675 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 287.57K | $22.97M | 新进 |
| Q4 2023 | 285.38K | $23.22M | 减持 |
| Q1 2024 | 284.88K | $25.84M | 持有 |
| Q2 2024 | 284.98K | $26.07M | 持有 |
| Q3 2024 | 282.80K | $26.87M | 减持 |
| Q4 2024 | 282.79K | $24.40M | 持有 |
| Q1 2025 | 283.69K | $25.85M | 持有 |
| Q2 2025 | 280.48K | $24.67M | 减持 |
| Q3 2025 | 275.40K | $24.89M | 减持 |
| Q4 2025 | 267.85K | $27.63M | 减持 |
| Q1 2026 | 267.70K | $27.81M | 持有 |
| Q2 2026 | 263.83K | $28.85M | 减持 |
| Q3 2026 | 254.16K | $27.82M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 PPH 与 13F 数据
PPH(VANECK PHARMACEUTICAL ETF)的行业分类暂缺。我们追踪的基金中还有 20 只申报持有 PPH,申报仓位最大的包括:J.Safra Asset Management Corp (US$35.9M), ADAMSBROWN WEALTH CONSULTANTS LLC (US$11.1M), Rye Brook Capital LLC (US$7.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 PPH 的基金
- J.Safra Asset Management Corp 328.31K 股 · $35.94M · Q3 2026
- ADAMSBROWN WEALTH CONSULTANTS LLC 101.70K 股 · $11.13M · Q3 2026
- Rye Brook Capital LLC 70.25K 股 · $7.69M · Q3 2026
- WT Wealth Management 47.80K 股 · $5.23M · Q3 2026
- Fortis Group Advisors, LLC 31.59K 股 · $3.77M · Q3 2026
- Fluent Financial, LLC 26.90K 股 · $2.94M · Q3 2026
更多关于 Avalon Trust Co
常见问题
How long has Avalon Trust Co held PPH?
Avalon Trust Co has disclosed PPH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Avalon Trust Co's current position in PPH?
As of Q3 2026, Avalon Trust Co holds 254.16K shares of PPH (VANECK PHARMACEUTICAL ETF), valued at $27.82M, representing 1.74% of its reported portfolio and ranking #13.
Has Avalon Trust Co been buying or selling PPH?
In the latest 13F filing (Q3 2026), Avalon Trust Co reduced its position in PPH. The position peaked in Q2 2026 at 263.83K shares.
Which other funds hold PPH?
Other major institutional holders of PPH include J.Safra Asset Management Corp, ADAMSBROWN WEALTH CONSULTANTS LLC, Rye Brook Capital LLC, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.